ALK-positive lymphoma: A single disease with a broad spectrum of morphology

Blood

Volumn 91, Issue 6, 1998, Pages 2076-2084

  Benharroch, Daniel ^b   Meguerian Bedoyan, Zarouhie ^b   Lamant, Laurence ^b   Amin, Chauki ^b   Brugières, Laurence ^b   Terrier Lacombe, Marie Jose ^b   Haralambieva, Eugenia ^b   Pulford, Karen ^b   Pileri, Stefano ^b   Morris, Stephan W ^b   Mason, David Y ^b   Delsol, Georges ^a  

^a CHU PURPAN   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALK PROTEIN; CD15 ANTIGEN; CHIMERIC PROTEIN; EPITHELIAL MEMBRANE ANTIGEN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CHROMOSOME 5Q; CHROMOSOME TRANSLOCATION 2; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0032521239     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.6.2076     Document Type: Article

References (39)

1. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R, Lennert K: The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848, 1985
2. Stansfeld A, Diebold J, Kapanci Y, Kelenyi G, Lennert K, Mioduszewska O, Noel H, Rilke F, Sundstrom C, van Unnik J, Wright D: Updated Kiel classification for lymphomas. Lancet 1:292, 1988
3. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri, SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
4. Rimokh R, Magaud JP, Berger F, Samarnt J, Coiffier B, Germain D, Mason DY: A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ("Ki-1 lymphoma3). Br J Haematol 71:31, 1989
5. Mason DY, Bastard C, Rimokh R, Dastugue N, Huret JL, Kristoffersson U, Magaud JP, Nezelof C, Tilly H, Vannier JP, Hemet J, Warnke R: CD30-positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35. Br J Haematol 74:161, 1990
6. Kaneko Y, Frizzera G, Edamura S, Maseki N, Sakurai M, Komada Y, Sakurai M, Tanaka H, Sasaki M, Suchi T, Kikuta A, Wakasa H, Hojo H, Mizutani S: A novel translocation t(2; 5) (p23; q35), in chilhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood 73:806, 1989
7. Bitter MA, Franklin WA, Larson RA, McKeithan TW, Rubin CM, Le Beau MM, Stephens JK, Vardiman JW: Morphology in Ki-1 (CD30) positive non-Hodgkin's lymphoma is correlated with clinical features and a unique chromosomal abnormality, t(2;5)(p23;q35). Am J Surg Pathol 14:305, 1990
8. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263:1281, 1994
9. NPM/ALK: A distinct clinicopathologic entity. Blood 86:1954, 1995
10. Pulford K, Lamant L, Morris SW, Butler L, Wood K, Stroud D, Delsol G, Mason DY: Detection of ALK and NPM-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood 89:1394, 1997
11. Delsol G, Lamant L, Mariamé B, Pulford K, Dastugue N, Brousset P, Rigal-Huguet F, Al Saati T, Cerretti DP, Morris SW, Mason DY: A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2;5 translocation. Blood 89:1483, 1997
12. Chan WC: The t(2;5) or NPM-ALK translocation in lymphomas: Diagnostic considerations. Adv Anat Pathol 3:396, 1996
13. Downing J, Shurtleff S, Zielenska M, Curcio-Brint AM, Behm FG, Head DR, Sandlund JT, Weisenburger D, Kossakowska AE, Thorner P, Lorenzana A, Ladanyi M, Morris S: Molecular detection of the t(2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Blood 85:3416, 1995
14. Arber D, Sun L-H, Weiss LM: Detection of the t(2;5) (p23;q35) chromosomal translocation in large B-cell lymphomas other than anaplastic large cell lymphoma. Hum Pathol 27:590, 1996
15. Weisenburger DD, Gordon BG, Vose JM, Bast MA, Chan WC, Greiner TC, Anderson JR, Sanger WG: Occurrence of the t(2;5) (p23;q35) in non-Hodgkin's lymphoma. Blood 87:3860, 1996
16. Lamant L, Meggetto F, Al Saati T, Brugières L, Bressac de Paillerets B, Dastugue N, Bernheim A, Rubie H, Terrier-Lacombe MJ, Robert A, Brousset P, Rigal F, Schlaifer D, Shiota M, Mori S, Delsol G: High incidence of the t(2;5) (p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. Blood 87:284, 1996
17. Herbst H, Anagnostopoulos J, Heinze B, Durkop H, Hummel M, Stein H: ALK gene products in anaplastic large cell lymphomas and Hodgkin's disease. Blood 86:1694, 1995
18. + anaplastic large cell lymphomas and in other non-Hodgkin's lymphomas of T-cell phenotype. Blood 86:2321, 1995
19. Stein H, Dallenbach F: Diffuse large cell lymphomas of B and T cell type, in Knowles, DM (ed): Neoplastic Hematopathology. Baltimore, MD, Williams and Wilkins, 1992, p 675
20. Pileri S, Falini B, Delsol G, Stein H, Baglioni P, Poggi S, Martelli MF, Rivano MT, Mason DY, Stansfeld AG: Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1+ with a high content of reactive histiocytes). Histopathology 16:383, 1990
21. Chan JKC, Buchanan R, Fletcher CDM: Sarcomatoid variant of anaplastic large cell Ki-1 lymphoma. Am J Surg Pathol 14:983, 1990
22. Kinney MC, Collins RD, Greer JP, Whitlock J, Sioutos N, Kadin M: A small cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma. Am J Surg Pathol 17:859, 1993
23. Mann KP, Hall B, Kamino H, Borowitz MJ, Ratech H: Neutrophilrich, Ki-1-positive anaplastic large cell malignant lymphoma. Am J Surg Pathol 19:407, 1995
24. Falini B, Liso A, Pasqualucci L, Flenghi L, Ascani S, Pileri S, Bucciarelli E: CD30+ anaplastic large cell lymphoma, null type, with signet ring appearance. Histopathol 30:90, 1997
25. Falini B, Pileri S, Pizzolo G, Durkop H, Flenghi L, Stirpe F, Martelli MF, Stein H: CD30 (Ki-1) molecule: A new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 85:1, 1995
26. Kuefer MU, Look AT, Tripp R, Behm FG, Pattengale PK, Morris SW: Retrovirus mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice. Blood 88:450a, 1996 (abstr, suppl 1)
27. Al Saati T, Tkaczuk J, Krissansen G, Print C, Pileri S, Ralfkiaer E, Grogan TM, Meggetto F, Delsol G: A novel antigen detected by the CBF.78 antibody further distinguishes anaplastic large cell lymphoma from Hodgkin's disease. Blood 86:2741, 1995
28. Delsol G, Blancher A, Al Saati T, Ralfkiaer E, Lauritzen A, Bruigeres L, Brousset P, Rigal-Huget F, Mazerolles C, Robert A, Chittal SM: Antibody BNH9 detects red blood cell-related antigens on anaplastic large cell (CD30+) lymphomas. Br J Cancer 64:321, 1991
29. Shi SR, Key ME, Kalra KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39:741, 1991
30. Al Saati T, Clamens S, Cohen-Knafo E, Faye JC, Prats H, Coindre JM, Wafflart J, Caverivière P, Bayard F, Delsol G: Production of monoclonal antibodies to human estrogen-receptor protein (ER) using recombinant ER (RER). Int J Cancer 55:651, 1993
31. Fraga M, Brousset P, Schlaifer D, Payen C, Robert A, Rubie H, Huguet-Rigal F, Delsol G: Bone marrow involvement in anaplastic large cell lymphoma. Am J Clin Pathol 103:82, 1995
32. Brousset P, Meggetto F, Chittal S, Bibeau F, Arnaud J, Rubin B, Delsol G: Assessment of the methods for the detection of the Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease. Lab Invest 69:483, 1993
33. Delsol G, Al Saati T, Gatter KC, Gerdes J, Schwarting R, Caverivière P, Rigal-Huguet F, Robert A, Stein H, Mason DY: Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphoma. Diagnostic value in so-called malignant histiocytosis. Am J Pathol 130:59, 1988
34. Brousset P, Rochaix P, Chittal S, Rubie H, Robert A, Delsol G: High incidence of Epstein-Barr virus detection in Hodgkin's disease and absence of detection in anaplastic large-cell lymphoma in children. Histopathology 23:189, 1993
35. Chittal SM, Delsol G: The interface of Hodgkin's disease and anaplastic large cell lymphoma. Cancer Surv 30:87, 1997
36. Delsol G, Stein H, Pulford KAF, Gatter KC, Erber WN, Zinne K, Mason DY: Human lymphoid cells express epithelial membrane antigen. Lancet 2:1124, 1984
37. Hilkens J, Ligtenberg MJL, Vos HL, Litvinov SV: Cell membrane associated mucins and their adhesion-modulating properties. Trends Biochem Sci 17:359, 1992
38. Swallow DM, Gendler S, Griffiths B, Keamey A, Povey S, Sheer D, Palmer RW, Taylor-Papamitriou J: The hypervariable gene locus PUM, which codes for the tumour associated mucins, is located on chromosome 1, within the region 1q21-24. Ann Hum Genet 51:289, 1987
39. Mason DY, Pulford KAF, Bischof D, Lamant L, Delsol G, Morris SW: Nucleolar localisation of the NMP-ALK tyrosine kinase is not required for malignant transformation. Cancer Res (in press)